|
1631 |
Prognostic assessment in patients with newly diagnosed small cell lung cancer brain metastases: results from a real-life cohort
Enthalten in Journal of neuro-oncology Bd. 145, 27.8.2019, Nr. 1, date:10.2019: 85-95
|
|
|
|
1632 |
Prognostic impact of circulating tumor cells assessed with the CellSearch System™ and AdnaTest Breast™ in metastatic breast cancer patients: the DETECT study
Enthalten in Breast cancer research Bd. 14, 15.8.2012, Nr. 4, date:8.2012: 1-8
|
|
|
|
1633 |
Prospective evaluation of serum tissue inhibitor of metalloproteinase 1 and carbonic anhydrase IX in correlation to circulating tumor cells in patients with metastatic breast cancer
Enthalten in Breast cancer research Bd. 13, 11.7.2011, Nr. 4, date:8.2011: 1-11
|
|
|
|
1634 |
Psychometric properties and minimal important differences of SF-36 in Idiopathic Pulmonary Fibrosis
Enthalten in Respiratory research Bd. 20, 1.3.2019, Nr. 1, date:12.2019: 1-11
|
|
|
|
1635 |
Q-HAM: a multicenter upfront randomized phase II trial of quizartinib and high-dose Ara-C plus mitoxantrone in relapsed/refractory AML with FLT3-ITD
Enthalten in Trials Bd. 24, 15.9.2023, Nr. 1, date:12.2023: 1-15
|
|
|
|
1636 |
Questionnaire-based detection of immune-related adverse events in cancer patients treated with PD-1/PD-L1 immune checkpoint inhibitors
Enthalten in BMC cancer Bd. 21, 24.3.2021, Nr. 1, date:12.2021: 1-10
|
|
|
|
1637 |
Rare brain biopsy findings in a first ADEM-like event of pediatric MS: histopathologic, neuroradiologic and clinical features
Enthalten in Journal of neural transmission Bd. 118, 10.3.2011, Nr. 9, date:9.2011: 1311-1317
|
|
|
|
1638 |
Reactive oxygen species induce tyrosine phosphorylation of and Src kinase recruitment to NO-sensitive guanylyl cyclase
Enthalten in BMC pharmacology Bd. 5, 16.6.2005, Nr. 1, date:6.2005: 1
|
|
|
|
1639 |
Reader comments to media reports on psychiatric neurosurgery: past history casts shadows on the future
Enthalten in Acta neurochirurgica Bd. 160, 24.10.2018, Nr. 12, date:12.2018: 2501-2507
|
|
|
|
1640 |
Real-world data suggest effectiveness of the allogeneic mesenchymal stromal cells preparation MSC-FFM in ruxolitinib-refractory acute graft-versus-host disease
Enthalten in Journal of translational medicine Bd. 21, 21.11.2023, Nr. 1, date:12.2023: 1-11
|
|
Administration
